91 related articles for article (PubMed ID: 21227627)
1. Preclinical pharmacokinetic analysis of SNX-2112, a novel Hsp90 inhibitor, in rats.
Zhai QQ; Gong GQ; Liu Z; Luo Y; Xia M; Xing GW; You XF; Wang YF
Biomed Pharmacother; 2011 Mar; 65(2):132-6. PubMed ID: 21227627
[TBL] [Abstract][Full Text] [Related]
2. Determination of SNX-2112, a selective Hsp90 inhibitor, in plasma samples by high-performance liquid chromatography and its application to pharmacokinetics in rats.
Zhai QQ; Gong GQ; Luo Y; Wang QD; Xia M; Xing GW; Li YC; Jiang JH; Liu Z; Liu QY; Wang YF
J Pharm Biomed Anal; 2010 Dec; 53(4):1048-52. PubMed ID: 20675090
[TBL] [Abstract][Full Text] [Related]
3. Preclinical pharmacokinetic analysis of felotaxel (SHR110008), a novel derivative of docetaxel, in rats and its protein binding ability in vitro.
Ding Y; Liu W; Lu C; Yang J; Zhu Y; Song Y; Ma Z; Yang L; Jia Y; Wen A
Biomed Pharmacother; 2012 Mar; 66(2):98-102. PubMed ID: 22264880
[TBL] [Abstract][Full Text] [Related]
4. P-glycoprotein (P-gp)-mediated efflux limits intestinal absorption of the Hsp90 inhibitor SNX-2112 in rats.
Liu H; Sun H; Wu Z; Zhang X; Wu B
Xenobiotica; 2014 Aug; 44(8):763-8. PubMed ID: 24555822
[TBL] [Abstract][Full Text] [Related]
5. Phospholipid-stabilized mesoporous carbon nanospheres as versatile carriers for systemic delivery of amphiphobic SNX-2112 (a Hsp90 inhibitor) with enhanced antitumor effect.
Zhang X; Zhang T; Ye Y; Chen H; Sun H; Zhou X; Ma Z; Wu B
Eur J Pharm Biopharm; 2015 Aug; 94():30-41. PubMed ID: 25936860
[TBL] [Abstract][Full Text] [Related]
6. Metabolite elucidation of the Hsp90 inhibitor SNX-2112 using ultraperformance liquid chromatography/quadrupole time-of-flight mass spectrometry (UPLC-QTOF/MS).
Liu W; Liu H; Sun H; Dong D; Ma Z; Wang Y; Wu B
Xenobiotica; 2014 May; 44(5):455-64. PubMed ID: 24191862
[TBL] [Abstract][Full Text] [Related]
7. Gender-related pharmacokinetics and absolute bioavailability of diosbulbin B in rats determined by ultra-performance liquid chromatography-tandem mass spectrometry.
Yang B; Wang X; Liu W; Zhang Q; Chen K; Ma Y; Wang C; Wang Z
J Ethnopharmacol; 2013 Oct; 149(3):810-5. PubMed ID: 23954278
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics, tissue distribution and excretion of a new photodynamic drug deuxemether.
Wang R; Hao H; Wang G; Xie H; Xu M; Wang W; He H; Li X
J Photochem Photobiol B; 2008 Mar; 90(3):179-86. PubMed ID: 18267365
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and disposition of L-692,429. A novel nonpeptidyl growth hormone secretagogue in preclinical species.
Leung KH; Cohn DA; Miller RR; Doss GA; Stearns RA; Simpson RE; Feeney WP; Chiu SH
Drug Metab Dispos; 1996 Jul; 24(7):753-60. PubMed ID: 8818572
[TBL] [Abstract][Full Text] [Related]
10. Recombinant human parathyroid hormone 1-34: pharmacokinetics, tissue distribution and excretion in rats.
Hu Z; Niu H; Yang X; Li H; Sang G; Li B
Int J Pharm; 2006 Jul; 317(2):144-54. PubMed ID: 16621369
[TBL] [Abstract][Full Text] [Related]
11. Small molecule inhibitors of Hsp90 potently affect inflammatory disease pathways and exhibit activity in models of rheumatoid arthritis.
Rice JW; Veal JM; Fadden RP; Barabasz AF; Partridge JM; Barta TE; Dubois LG; Huang KH; Mabbett SR; Silinski MA; Steed PM; Hall SE
Arthritis Rheum; 2008 Dec; 58(12):3765-75. PubMed ID: 19035474
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics, tissue distribution and excretion of gambogic acid in rats.
Hao K; Liu XQ; Wang GJ; Zhao XP
Eur J Drug Metab Pharmacokinet; 2007; 32(2):63-8. PubMed ID: 17702192
[TBL] [Abstract][Full Text] [Related]
13. Preclinical pharmacology of the natural product anticancer agent 10-hydroxycamptothecin, an inhibitor of topoisomerase I.
Zhang R; Li Y; Cai Q; Liu T; Sun H; Chambless B
Cancer Chemother Pharmacol; 1998; 41(4):257-67. PubMed ID: 9488594
[TBL] [Abstract][Full Text] [Related]
14. The Hsp90 inhibitor SNX-2112, induces apoptosis in multidrug resistant K562/ADR cells through suppression of Akt/NF-κB and disruption of mitochondria-dependent pathways.
Wang R; Shao F; Liu Z; Zhang J; Wang S; Liu J; Liu H; Chen H; Liu K; Xia M; Wang Y
Chem Biol Interact; 2013 Sep; 205(1):1-10. PubMed ID: 23777986
[TBL] [Abstract][Full Text] [Related]
15. Comparative effects of SNX-7081 and SNX-2112 on cell cycle, apoptosis and Hsp90 client proteins in human cancer cells.
Wang X; Wang S; Liu Y; Huang D; Zheng K; Zhang Y; Wang X; Liu Q; Yang D; Wang Y
Oncol Rep; 2015 Jan; 33(1):230-8. PubMed ID: 25334086
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics, biodistribution and bioavailability of isoliquiritigenin after intravenous and oral administration.
Qiao H; Zhang X; Wang T; Liang L; Chang W; Xia H
Pharm Biol; 2014 Feb; 52(2):228-36. PubMed ID: 24102672
[TBL] [Abstract][Full Text] [Related]
17. Plasma pharmacokinetics and tissue distribution of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) in CD2F1 mice1.
Egorin MJ; Zuhowski EG; Rosen DM; Sentz DL; Covey JM; Eiseman JL
Cancer Chemother Pharmacol; 2001 Apr; 47(4):291-302. PubMed ID: 11345645
[TBL] [Abstract][Full Text] [Related]
18. The Hsp90 inhibitor SNX-2112 induces apoptosis of human hepatocellular carcinoma cells: the role of ER stress.
Wang X; Wang S; Liu Y; Ding W; Zheng K; Xiang Y; Liu K; Wang D; Zeng Y; Xia M; Yang D; Wang Y
Biochem Biophys Res Commun; 2014 Mar; 446(1):160-6. PubMed ID: 24582562
[TBL] [Abstract][Full Text] [Related]
19. SNX-2112, an Hsp90 inhibitor, induces apoptosis and autophagy via degradation of Hsp90 client proteins in human melanoma A-375 cells.
Liu KS; Liu H; Qi JH; Liu QY; Liu Z; Xia M; Xing GW; Wang SX; Wang YF
Cancer Lett; 2012 May; 318(2):180-8. PubMed ID: 22182451
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics, tissue distribution and excretion of vinflunine.
Zhao XP; Liu XQ; Wang YS; Wang H; Wang GJ
Eur J Drug Metab Pharmacokinet; 2006; 31(2):59-64. PubMed ID: 16898072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
